Alison Taunton-Rigby

Alison Taunton-Rigby founded RiboNovix, Inc. in 2003, where she worked as Chief Executive Officer in 2010.
Dr. Taunton-Rigby also currently works at RiverSource Family of Mutual Funds, as Director, AbCellera Boston, Inc., as Director from 2019, Mount Ida College, as Director from 2016, International Relief & Development, Inc., as Director, ICI Mutual Insurance Co., as Director from 2011, Boston Children's Heart Foundation, Inc., as Trustee, The Children's Hospital Corp., as Trustee from 2002, and The Children's Medical Center Corp., as Trustee.
Dr. Taunton-Rigby also formerly worked at Cambridge Biotech Corp., as President & Chief Executive Officer from 1995 to 1996, Aquila Biopharmaceuticals, Inc., as President & Chief Executive Officer from 1995 to 2000, GPC Biotech, Inc., as President & Chief Executive Officer in 2003, CMT, Inc., as President & Chief Executive Officer from 2001 to 2003, Tivity Health, Inc., as Independent Director from 2011 to 2016, Tri-Continental Corp., as Independent Director from 2008 to 2017, Idera Pharmaceuticals, Inc., as Director, Abt Associates, Inc., as Director from 2001 to 2016, RiverSource LaSalle International Real Estate Fund, Inc., as Director from 2008 to 2011, Columbia Seligman Premium Technology Growth Fund, Inc., as Independent Director from 2012 to 2018, The International Women's Forum, as Director, Genzyme Corp., as Senior Vice President-Biotherapeutics in 2003, and Arboretum Ventures LLC, as Advisory Board Member.
Dr. Taunton-Rigby received her doctorate degree from the University of Bristol.